News Announcement

Pfizer: Unaudited Financial Results For The Quarter And Half Year Ended
September 30 2022

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the unaudited financial results for the quarter and
half year ended September 30 2022. The said results were approved by the Board of Directors of the Company at its Meeting held today that commenced at 2.15 p.m. and
concluded at 4.00 p.m.

Also please find enclosed the Limited Review Report by our Auditors M/s. B S R & Co. LLP in respect of the above results.

Please take the above on record

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.